|
STD Graffiti
Treatments described in the medical news section may not be available in all countries. We do not sell the listed medicines. Drugs may have side effects not mentioned here. Cancers attributable to human papillomavirus (HPV) infection: HPV is detected in 70% of vaginal cancers, 40% of vulval cancer, 50 % of penile cancer, 85 % of anal cancer, and 35 % of oropharyngeal cancer. Sexual health 2010 Sep; 7(3):244 Persistent infection with Human Papilloma virus (HPV) is the principal cause of cervical cancer in women. HPV is implicated in 99 percent of cervical cancers. High risk HPV genotypes are: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68 Cumulative risks of subsequent cervical cancer for women with HPV16, HPV58, or other carcinogenic HPV types were 13 %, 10 %, and 4 %, respectively, compared with 0.3 % for HPV-negative women. Sixteen year follow up study of women aged above 30 years. Journal of National Cancer Institute 2011 Sep 21;103(18):1387 Human Papillomavirus vaccine, Cervarix is 100 percent effective against cervical cancer in young women, who were not infected with HPV before they were immunized. The vaccine is 77 percent effective against cancer in general population of women (who may or may not have been previously exposed to HPV) Lancet Oncology 8 Nov 2011 Cervarix vaccine effectively prevents CIN3+, the pre-cancer lesion of cervix. The vaccine is 100 percent effective against pre cancer CIN3 lesions associated with HPV 16 and HPV 18 strains, in previously unexposed women. Vaccine was 46 percent effective against CIN3 in general population of women, who may or may not have been previously exposed to HPV. Lancet Oncology 8 Nov 2011 Women infected with the human papillomavirus (HPV), are 2.3 times as likely as uninfected women to have had a heart attack or stroke. HPV inactivates a gene called p53, which normally protects the body from cancer and may also prevent thickening of artery. While the findings show an association between virus and heart disease, it is not proved that the virus caused the disease. Journal of the American College of Cardiology, 1 November 2011; 58: 2001 Human papillomavirus infections among young heterosexual attendees in STD Clinic: Prevalence of HPV and high risk HPV were higher in females. HPV prevalence was 72 % among females and 54 % among males. High-risk HPV was present 58 % and 40 % in females and males, respectively. Sexually Transmitted Diseases December 2011; 38 (12) More than 100 types of Human Papilloma virus (HPV) exist, more than 40 of which can infect the genital area. Centers for Disease Control and Prevention, Atlanta, USA
Human papillomavirus (HPV) is an increasing cause of oro-pharyngeal squamous cell carcinoma. The incidence of HPV associated cancers of throat has increased 7-fold over 30 years. International Journal of Cancer 2009; 125: 362
HPV vaccine, Gardasil significantly reduces the rate of anal intraepithelial neoplasia among gay men. New England Journal of Medicine 2011 Oct 27; 365:1576
Human papilloma virus (HPV) type 16 is increasingly being identified in throat cancers. Sexually transmitted HPV 16 is known to cause cervical cancer in women. Throat cancers caused by the virus have increased to 2.6 per 100,000 people in 2004 from 0.8 cases per 100,000 people in 1988. If the trend continues, by 2020 the virus will be causing more throat cancer than cervical cancer. Virus-related throat cancers are far more common in men than in women, a difference that has not been explained. The Journal of Clinical Oncology, Advance online October 3, 2011
Persistent infection with Human Papilloma virus (HPV) is the principal cause of cervical cancer in women. HPV is implicated in 99 percent of cervical cancers.
Nearly a quarter of a million women die each year from cervical cancer, 80 percent of them in developing countries. World Health Organization
Development of cervical cancer in women who have human papilloma virus infection of the cervix may be due to the activation of the beta-catenin oncogene in the cervix. American Association for Cancer Research 102nd Annual Meeting 2011
The CDC Advisory Committee on Immunization Practices (ACIP) has approved routine vaccination of 11- and 12-year-old boys with Gardasil to protect against human papillomavirus on 25 October 2011. The committee also recommended the vaccination for males 13 through 21 years who have not been vaccinated previously or who have not completed the three-dose series.
Gardasil, vaccine against HPV was approved by FDA for girls and women ages 9 to 26 on 9 June 2006. Gardasil won FDA approval for use in males on 17 October 2009.
Eight human papilloma virus (HPV) types responsible for more than 90% of cervical cancer cases have been identified. They are types 16, 18, 45, 33, 31, 52, 58, and 35 in descending order of frequency. They should be the targets for the next generation of vaccines. The Lancet Oncology HPV types 16 and 18 have been identified as the highest risk genotypes, detected in approximately 70 percent of cervical cancers.
Cancerous and pre-cancerous cell changes are detected in a high proportion of anal warts surgically removed from gay men. The findings are very significant, as anal warts are classically associated with low-risk HPV types. Clinical Infectious Diseases July 1, 2010
Condom use by couples in long-term partnerships may decrease the time to clear Human papilloma virus (HPV) in the infected woman. Transmission of HPV between sexual partners might maintain viral infection and, consequently, may influence the clinical course. International Journal of Cancer 2003 Dec 10;107(5):811 Human papilloma virus (HPV) vaccine Gardasil is designed to prevent infection with HPV types 6, 11, 16, and 18. In addition, the vaccine offered nearly 40% cross-protection against ten types of HPV-31, 33, 35, 39, 45, 51, 52, 56, 58, and 59. Oncology Times: 25 October 2007; 29 (20) Screening for Human papilloma virus (HPV) is superior to Pap smear in preventing invasive cervical cancer in women over 35. Lancet Oncology 2010 Human Papilloma virus (HPV) vaccination is trailing other vaccines recommended in teenage. Centers for Disease Control and Prevention HPV vaccination in pregnancy: Administration of the quadrivalent HPV vaccine during pregnancy is not associated with excess risk for adverse outcomes. Obstet Gynecol 2009 Dec Vaccine against HPV-16/18 remained highly effective for more than 6 years after administration. Lancet 2009 Dec. Healthy women younger than 65 should undergo Pap test every three years. The screening test should start at age of 21, regardless of the sexual activity. U.S. Preventive Services Task Force, Revised Recommendation, October 19, 2011 STD CLINIC DUBAI HIV Test STDs Clinic Genital Wart Herpes Hepatitis B Hepatitis C Syphilis Gonorrhea Chlamydia Trichomoniasis L G V |